{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:39:22Z","timestamp":1788925162779,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.atherosclerosis.2024.119046","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T16:26:00Z","timestamp":1730478360000},"page":"119046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Readmission outcomes after acute coronary syndrome among patients with myeloproliferative neoplasms"],"prefix":"10.1016","volume":"401","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3006-6380","authenticated-orcid":false,"given":"Orly","family":"Leiva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"How","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119046_bib1","first-page":"166","article-title":"Cardiovascular disease in myeloproliferative neoplasms","volume":"4","author":"Leiva","year":"2022","journal-title":"JACC: CardioOncology"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119046_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaccao.2023.03.014","article-title":"Outcomes of patients with myeloproliferative neoplasms admitted with myocardial infarction: insights from national inpatient sample","volume":"5","author":"Leiva","year":"2023","journal-title":"JACC CardioOncol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.119046_bib3","first-page":"895","article-title":"Myeloproliferative neoplasms","volume":"377","author":"Spivak","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119046_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ajh.26751","article-title":"The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms","volume":"98","author":"Thiele","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.119046_bib5","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/CIRCRESAHA.118.313283","article-title":"Macrophage inflammation, erythrophagocytosis, and accelerated atherosclerosis in Jak2 (V617F) mice","volume":"123","author":"Wang","year":"2018","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.119046_bib6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/jama.2022.0358","article-title":"Diagnosis and treatment of acute coronary syndromes: a Review","volume":"327","author":"Bhatt","year":"2022","journal-title":"JAMA"},{"issue":"10065","key":"10.1016\/j.atherosclerosis.2024.119046_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0140-6736(16)30677-8","article-title":"Acute myocardial infarction","volume":"389","author":"Reed","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.119046_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MCA.0000000000000844","article-title":"Unplanned hospital readmissions after acute myocardial infarction: a nationwide analysis of rates, trends, predictors and causes in the United States between 2010 and 2014","volume":"31","author":"Kwok","year":"2020","journal-title":"Coron. Artery Dis."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119046_bib9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/hematolrep15020040","article-title":"Risk factors for death or cardiovascular events after acute coronary syndrome in patients with myeloproliferative neoplasms","volume":"15","author":"Leiva","year":"2023","journal-title":"Hematol. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.119046_bib10","article-title":"Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners","volume":"367","author":"Desai","year":"2019","journal-title":"BMJ"},{"issue":"7853","key":"10.1016\/j.atherosclerosis.2024.119046_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","article-title":"The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis","volume":"592","author":"Fidler","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119046_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s42003-022-03078-5","article-title":"Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol efflux","volume":"5","author":"Dotan","year":"2022","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119046_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jaccao.2022.04.002","article-title":"Cardiovascular disease in myeloproliferative neoplasms: JACC: CardioOncology state-of-the-art Review","volume":"4","author":"Leiva","year":"2022","journal-title":"JACC CardioOncol"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2024.119046_bib14","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","article-title":"Myeloproliferative neoplasms and thrombosis","volume":"122","author":"Barbui","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119046_bib15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jacbts.2019.05.013","article-title":"JAK2 (V617F) -mediated clonal hematopoiesis accelerates pathological remodeling in murine heart failure","volume":"4","author":"Sano","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119046_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacbts.2019.08.006","article-title":"Clonal hematopoiesis: a New step linking inflammation to heart failure","volume":"5","author":"Yura","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.atherosclerosis.2024.119046_bib17","article-title":"In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and heart failure: insights from the National Readmissions Database","volume":"49","author":"Leiva","year":"2023","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.atherosclerosis.2024.119046_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12185-022-03454-1","article-title":"Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease","volume":"117","author":"Leiva","year":"2022","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.atherosclerosis.2024.119046_bib19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jjcc.2022.10.007","article-title":"Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation","volume":"81","author":"Leiva","year":"2022","journal-title":"J. Cardiol."},{"issue":"Suppl_1","key":"10.1016\/j.atherosclerosis.2024.119046_bib20","doi-asserted-by":"crossref","first-page":"A10079","DOI":"10.1161\/circ.144.suppl_1.10079","article-title":"Abstract 10079: risk of cardiovascular and all-cause mortality in patients with myeloproliferative neoplasms following heart failure hospitalization","volume":"144","author":"Leiva","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.119046_bib21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1164\/rccm.202306-1001ED","article-title":"Pulmonary hypertension in myeloproliferative neoplasms: New insights and unexplored horizons","volume":"208","author":"Leiva","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.119046_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12185-022-03454-1","article-title":"Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease","volume":"117","author":"Leiva","year":"2023","journal-title":"Int. J. Hematol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.119046_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/bjh.16576","article-title":"Myelofibrosis biology and contemporary management","volume":"191","author":"Gangat","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119046_bib24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s12185-019-02751-6","article-title":"Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice","volume":"110","author":"Leiva","year":"2019","journal-title":"Int. J. Hematol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.119046_bib25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood-2017-04-777417","article-title":"Upregulation of lysyl oxidase and adhesion to collagen of human megakaryocytes and platelets in primary myelofibrosis","volume":"130","author":"Abbonante","year":"2017","journal-title":"Blood"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024012188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024012188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:49:17Z","timestamp":1741844957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024012188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":25,"alternative-id":["S0021915024012188"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.119046","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Readmission outcomes after acute coronary syndrome among patients with myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.119046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119046"}}